Clinical Trial Detail

NCT ID NCT03210662
Title Pembrolizumab and Fractionated External Beam Radiotherapy (EBRT) in Patients With Non-Hodgkin Lymphoma (NHL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.